Overview
Financials
Revenue history (in m)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 333 days for 2023). 5 of 6 audited by a statutory auditor.
- 2025not filed
- 202428/01/2026
- 202313/06/2025
- 202206/07/2023
- 202123/09/2022
- 202014/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Public procurement
1 tender recorded as contractor.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| May 5, 2025 | Framework agreement on behalf of the AOU IRCCS of Bologna for the procurement of gametes for heterologous medically assisted reproduction (MAR) techniques for the regional gamete bank located at | $5.2M$5,197,790 | AZIENDA USL DI BOLOGNA |
National Health Fund (NFZ) contracts
Gyncentrum has been an NFZ healthcare provider since 2019. In 2026 it is performing 5 contracts with a total value of USD 2.85m. All its contracts were worth USD 15.36m in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Preventive health programmes | śląskie | 1 | USD 1.83m |
| Preventive health programmes | małopolskie | 1 | USD 424.49k |
| Preventive health programmes | dolnośląskie | 1 | USD 323.00k |
| Preventive health programmes | lubelskie | 1 | USD 202.87k |
| Preventive health programmes | wielkopolskie | 1 | USD 72.38k |
Trademarks
Gyncentrum holds 9 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2011.
| Mark | Protected until | |
|---|---|---|
| holsä APP | Jan 25, 2033 | |
| Fertiscreen Genetic Preconception Test | Oct 14, 2032 | |
| Fertigen Infertility Genetic Test men | Oct 14, 2032 | |
| Fertigen Infertility Genetic Test woman | Oct 12, 2032 | |
| Mitotest Mitochondrial DNA Analysis | May 30, 2032 |
Authorized Representatives
Manner of representation
The company is represented by each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Czerwińscy Fundacja Rodzinna | 100 | $270,124.26 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Holsa Medicalsp. z o.o. | 27,012.43 USD | 100% | ||
Ferti Pharmsp. z o.o. | 297,136.68 USD | 100% |
Bank accounts
Registered as a VAT taxpayer on 2019-07-04.
69 1050 1214 1000 0090 8112 7905- 33 1050 1214 1000 0090 8366 4327
- 70 1050 1214 1000 0090 8095 6585
Debt
No entries in the National Debtors Register (KRZ).
Public aid
15 public aid cases recorded, with a total value of $1,451,064.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 15, 2022 | Aid for research and development projects: industrial research | $417.4K$417,399 | Marszałek Województwa Śląskiego | |
| Jun 15, 2022 | Aid for research and development projects: experimental development | $139.9K$139,884 | Marszałek Województwa Śląskiego | |
| Jun 15, 2022 | Aid for process and organisational innovation | $0$0 | Marszałek Województwa Śląskiego |
European Funds
5 projects co-financed from European Funds recorded, with total EU co-financing of $3,657,603.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-07-01 | Conducting R&D work to develop a dual CAR-T technology that is innovative on a scale unknown and not previously used, and to launch chimeric antigen receptors for modifying patients' T lymphocytes for multiple myeloma therapy. | $765.6K$765,616 | Regional Operational Programme for the Śląskie Voivodeship for 2014-2020 | |
| 2020-08-01 | NI PGT-A – conducting research and development work to bring non-invasive preimplantation aneuploidy diagnostics to market | $635.3K$635,251 | Regional Operational Programme for the Śląskie Voivodeship for 2014-2020 | |
| 2020-05-01 | Preventing the spread of COVID-19 by equipping the GYNCENTRUM Sp. z o.o. laboratory with specialist equipment for the automated isolation of nucleic acids. | $1.1M$1,145,913 | Regional Operational Programme for the Śląskie Voivodeship for 2014-2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ScanixS.A. | $9,098,658.19 | scanix.pl | ||
| Dunique Isp. z o.o. | $4,452,307.85 | dunique.pl | ||
| Telemedycyna PolskaS.A. | $1,326,705.70 | telemedycynapolska.pl | ||
| Zakrzewscy Clinicsp. z o.o. | $1,298,046.10 | klinikazakrzewscy.pl | ||
| Niepubliczny Zakład Opieki Zdrowotnej Med-Voxsp. z o.o. | $713,781.77 | med-vox.pl | ||
| Dermocentrumsp. z o.o. | $570,497.15 | dermocentrum.pl | ||
| Medsidesp. z o.o. | $176,482.42 | medside.pl | ||
| Estesissp. z o.o. | $62,782.24 | estesis.pl | ||
| Polskie Szpitale Plastycznesp. z o.o. | $34,845.08 | stachura-drozd.com | ||
| DR Knastsp. z o.o. | $1,785.53 | drknast.pl |
FAQ
Last updated: 2026-10-07